| Titre | Une approche hedonique de la formation des prix des médicaments remboursables | |
|---|---|---|
| Auteur | Julien Werle, Vincent Perrin, Edouard Martin, Stéphane Jacobzonne | |
 |
Revue | Economie et prévision |
| Numéro | no 129-130, 1997/3-4 Nouvelles approches micro-économiques de la santé | |
| Rubrique / Thématique | Nouvelles approches micro-économiques de la santé Les outils d'analyse et de mesure en économie de la santé |
|
| Page | 73-99 | |
| Résumé anglais |
Reimboursed drugs price setting: a hedonic approach by Stéphane Jacobzone, Edouard Martin, Vincent Perrin and Julien Werle
A hedonic pricing model is used to describe price setting in the case of reimbursed drugs in France. The data used cover 24 % of the French market over the period 1980-1993, allow for a detailed description of physical and chemical properties of the products, and have been matched with business survey data. They pertain to two main therapeutic classes (anti-ulcer drugs, antihypertensive drugs).
lucts, from
the effects of changing market structure. These indices, which are adjusted for quality, grow more rapidly than official indices, the bias averaging 20 %. Price dynamics also depend on whether the product is innovative or not. This effect has not been found in other studies. It suggests that given their environment firms have an incentive to introduce, new - and therefore more expensive- drugs. Source : Éditeur (via Persée) |
|
| Article en ligne | http://www.persee.fr/web/revues/home/prescript/article/ecop_0249-4744_1997_num_129_3_5865 |
